CRL vs TMP · rev $4.05B vs P/E 7.5, rev $79.3M
Charles River Laboratories (CRL) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported CRL revenue for 2024-12-28 was $4.05B. Net income was $25.3M. Revenue was down 1.9% from 2023-12-30 to 2024-12-28. CRL currently screens at market cap $7.78B.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
CRL currently screens at market cap $7.78B. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the CRL and TMP stock pages for the full models.
Not investment advice.